Results 281 to 290 of about 54,917 (299)

Ipragliflozin and Other Sodium–Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Type 2 Diabetes: Preclinical and Clinical Data

Pharmacology & Therapeutics, 2013
Hideaki Ogasawara, Eiji Kurosaki
exaly  

The Serendipitous Story of SGLT2 Inhibitors in Heart Failure

Circulation, 2019
Subodh Verma, John McMurray
exaly  

SGLT2 inhibitors

British Journal of Cardiology, 2017
openaire   +1 more source

SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials

Lancet, The, 2020
Faiez Zannad, Javed Butler, Waheed Jamal
exaly  

MODULATION OF SGLT2 EXPRESSION

2005
FREIER SUSAN M, WANCEWICZ EDWARD, MONIA BRETT P, SIWKOWSKI ANDREW M, WATTS LYNETTA, LEEDOM THOMAS A   +5 more
openaire   +4 more sources

SGLT2 Inhibition — A Novel Strategy for Diabetes Treatment

Nature Reviews Drug Discovery, 2010
Robert R Henry
exaly  

SGLT2-Hemmer

Diabetes aktuell, 2016
openaire   +1 more source

SGLT2 Inhibitors and Mechanisms of Cardiovascular Benefit: A State-of-the-Art Review

Diabetologia, 2018
Subodh Verma, John McMurray
exaly  

Glucose Dynamics and Mechanistic Implications of SGLT2 Inhibitors in Animals and Humans

Kidney International, 2011
Jean M Whaley, James F List
exaly  

Elevated Serum Magnesium Associated With SGLT2 Inhibitor Use in Type 2 Diabetes Patients: A Meta-Analysis of Randomised Controlled Trials

Diabetologia, 2016
Yiqing Song, Xi Zhang, Jingjing Zhang
exaly